Characterizing inflammatory biomarkers in poststroke seizure risk and outcome prognostication
Document Type
Article
Publication Date
3-1-2026
Abstract
Post-stroke seizures (PSS) are sequelae of intracerebral hemorrhage (ICH) that may negatively impact patient outcomes. Available literature suggests that inflammatory biomarkers contribute to epileptogenesis as well as mortality. This retrospective cohort study aimed to elucidate the prognostic ability of CCL2, IL6, and IL8 in PSS development. ICH data were collected at Yale New Haven Hospital from 2014 to 2021. Plasma biomarker levels were measured via cytometric bead array. Patients with EEG-recorded epileptiform discharges, EEG-recorded seizures, or clinical seizures after ICH were defined as seizures and epileptiform discharges (SED), while those without were defined as non-SED. SED was further divided into early and late, occurring before and 7 days post-ICH, respectively. Additionally, we examined if biomarkers were associated with poor outcome (modified Rankin Scale score of 3–6) and mortality at 90, 180, and 365 days post-ICH. We conducted univariable and multivariable logistic regression analyses and reported the findings as Odds Ratio (OR) and 95% CI. We examined 172 patients with ICH, of whom 33 had early SED, 29 had late SED, and 110 had no SED. In univariable analyses, CCL2, ICH volume, diabetes, and lobar ICH were significantly associated with late SED, whereas NIHSS score at admission, ICH volume, and lobar ICH were significantly associated with early SED (p < 0.05). Lower CCL2 levels were independent predictors of late SED in multivariable analyses (OR 0.58; 95% CI 0.41–0.80, p < 0.001), but not of early SED. Additionally, we identified an independent association between higher CCL2 levels and 90-day mortality in multivariable analysis for the combined early and late SED cohorts (OR 1.87; 95% CI 1.03–3.37, p = 0.038). Additional studies investigating additional aspects of biomarkers, such as their temporal profile post-stroke within 24 hours or beyond 72 hours, are needed.
Keywords
Aged; Aged, 80 and over; Biomarkers; Cerebral Hemorrhage; Chemokine CCL2; Female; Humans; Inflammation; Interleukin-6; Interleukin-8; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Seizures; Stroke; biological marker; interleukin 6; interleukin 8; monocyte chemotactic protein 1; biological marker; CCL2 protein, human; IL6 protein, human; interleukin 6; interleukin 8; monocyte chemotactic protein 1
Publication Title
Plos One
ISSN
1932-6203
DOI
10.1371/journal.pone.0345752
Recommended Citation
Wang, Ethan Y.; Misra, Shubham; Yan, Jennifer; Chook, Pei Yi; Kawamura, Yuki; Kitagawa, Rachel; Kim, Jennifer A.; Gilmore, Emily J.; de Havenon, Adam; Sivaraju, Adithya; Hirsch, Lawrence J.; Falcone, Guido J.; Rangaraju, Srikant; Sansing, Lauren H.; Magid-Bernstein, Jessica; and Mishra, Nishant K., "Characterizing inflammatory biomarkers in poststroke seizure risk and outcome prognostication" (2026). Research Publications (2026 to 2030). 1115.
https://knova.um.edu.my/research_publications_2026_2030/1115
Volume
21
Issue
3 March
Publisher
Public Library of Science